HIV-specific antibody-dependent phagocytosis matures during HIV infection
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HIV-specific antibody-dependent phagocytosis matures during HIV infection
Authors
Keywords
-
Journal
IMMUNOLOGY AND CELL BIOLOGY
Volume 92, Issue 8, Pages 679-687
Publisher
Wiley
Online
2014-06-10
DOI
10.1038/icb.2014.42
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines
- (2014) A. W. Chung et al. Science Translational Medicine
- A Programmable Sensor to Probe the Internalization of Proteins and Nanoparticles in Live Cells
- (2013) Haiyin Liu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys
- (2013) Dan H. Barouch et al. CELL
- Enhanced Phagocytic Activity of HIV-Specific Antibodies Correlates with Natural Production of Immunoglobulins with Skewed Affinity for Fc R2a and Fc R2b
- (2013) M. E. Ackerman et al. JOURNAL OF VIROLOGY
- Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques
- (2013) C Moog et al. Mucosal Immunology
- Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG
- (2013) G. D. Tomaras et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Association of Fc receptor IIIa genotype with the rate of HIV infection after gp120 vaccination
- (2012) D. N. Forthal et al. BLOOD
- Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection
- (2012) Leia H. Wren et al. IMMUNOLOGY
- Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family
- (2012) M. Bonsignori et al. JOURNAL OF VIROLOGY
- B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study
- (2012) Barton F Haynes et al. NATURE BIOTECHNOLOGY
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
- (2012) Barton F. Haynes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activation of NK Cells by ADCC Antibodies and HIV Disease Progression
- (2011) Amy W Chung et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- NK Cell Function and Antibodies Mediating ADCC in HIV-1-Infected Viremic and Controller Patients
- (2011) Susanne E. Johansson et al. VIRAL IMMUNOLOGY
- Decreased Fc receptor expression on innate immune cells is associated with impaired antibody-mediated cellular phagocytic activity in chronically HIV-1 infected individuals
- (2011) Anne-Sophie Dugast et al. VIROLOGY
- Vaccine-induced IgG2 anti-HIV p24 is associated with control of HIV in patients with a ‘high-affinity’ FcγRIIa genotype
- (2010) Martyn A French et al. AIDS
- A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples
- (2010) Margaret E. Ackerman et al. JOURNAL OF IMMUNOLOGICAL METHODS
- The Humoral Response to HIV‐1: New Insights, Renewed Focus
- (2010) Galit Alter et al. JOURNAL OF INFECTIOUS DISEASES
- Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers
- (2009) Olivier Lambotte et al. AIDS
- Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?
- (2009) Leonidas Stamatatos et al. NATURE MEDICINE
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- Induction of HIV-1 subtype B and AE-specific neutralizing antibodies in mice and macaques with DNA prime and recombinant gp140 protein boost regimens
- (2009) Rob J. Center et al. VACCINE
- Fc receptor-mediated antiviral antibodies
- (2009) Donald N Forthal et al. Current Opinion in HIV and AIDS
- Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers
- (2009) Ann J. Hessell et al. PLoS Pathogens
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started